In this study, treatment of mice bearing Wnt1/iR1 tumors with BGJ398 [22], a potent and selective inhibitor of the FGFR family of receptor tyrosine kinases, resulted in an altered collagen-enriched stroma observed both during tumor dormancy and recurrence. The gene discussed is WNT1; the disease is neoplasm.